Leukemia Clinical Trials in Los Angeles

Showing 1101-1120 of 1,175 trials

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00015834

Phase I/II trial to study the effectiveness of combining STI571 and chemotherapy in treating patients who have chronic myelogenous leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. STI571 may stop the growth of leukemia cells. Combining chemotherapy and STI571 may kill more cancer cells

Blastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveRelapsing Chronic Myelogenous Leukemia

National Cancer Institute (NCI)46 participantsStarted May 2001

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Iressa Expanded Access Program (EAP)

NCT00034879

A program for patients with non small cell lung cancer who may benefit from Iressa, but cannot enter another clinical trial due to them not being eligible, or for whom no trials are available.

CarcinomaNon-small-cell LungMetastases+1 more

AstraZenecaStarted Aug 2000

Alabaster, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +623 more locations

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Iressa Expanded Access Program (EAP)

Leukemia Trials in Other Cities

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

S9912 Combination Chemo in Stage III Ovarian Cancer,

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Topotecan in Treating Children With Refractory Leukemia

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Other Conditions in Los Angeles